Theodore E Warkentin. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antibody FormationAnticoagulants/adverse effectsAnticoagulants/immunologyAnticoagulants/therapeutic useFemaleHeparin/adverse effectsHeparin/immunologyHeparin/therapeutic useHumansMalePipecolic Acids/therapeutic useThrombocytopenia/chemically inducedThrombocytopenia/etiologyThrombocytopenia/therapyVenous Thrombosis/drug therapyWarfarin/adverse effectsWarfarin/therapeutic use
Substances: See more » AnticoagulantsPipecolic AcidsWarfarinHeparinargatroban
Year: 2005 PMID: 15900266 DOI: 10.1016/j.disamonth.2005.03.009
Source DB: PubMed Journal: Dis Mon ISSN: 0011-5029 Impact factor: 3.800